… This difference in the clinical characteristics probably contributed to the substantially poorer
tumor response and disease control in this study (Eighteen of 19 evaluable patients had …

… erlotinib and gefitinib has been confirmed, especially in Asian … patients with adenocarcinoma,
and as a consequence seven EGFR mutated patients in our study (1.5%) received erlotinib …

… non-small cell lung cancer (NSCLC) patients who have failed of gefitinib or erlotinib treatment
in second/third-line treatment. The aim of this study was to investigate the efficacy of re-…

… Since our patient was elderly, the dosages used in this study were lower than those in
another report. However, our treatment effectively reduced tumor growth, with some adverse …

… cardiovascular effects of erlotinib and gefitinib. As cardiologists in a hospital for patients
with cancer, we … To the Editor: In their discussion of the clinical use of erlotinib or gefitinib in …

… this study was to determine the response rate of gefitinib 500 mg/day in pretreated patients
… Another important goal was to analyze the pharmacodynamic effects of gefitinib in the tumor, …

… The purpose of this study was to compare clinical outcomes of Erlotinib versus Gefitinib in
the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma and newly …

… Although this study did not demonstrate the superiority of gefitinib plus simvastatin as a … in
unselected NSCLC patients, the improved efficacy of this combination in the patients with wild-…

… patients were required for this study. For analysis, we included all patients who received at
least one dose of study … For efficacy analysis, we included all patients enrolled in this study. …

… -line erlotinib or gefitinib with cytotoxic chemotherapy in patients … With the ErbB family blocker
afatinib, patients experienced … to reports from studies using gefitinib or erlotinib. However, …